Datasets:
ESGBERT
/
base_data

Dataset card Data Studio Files
xet
 Community
sentence
stringlengths
1
23.5k
⌀
of healthcare, Waters places a high importance on supporting global charitable efforts to further improve the quality of life in the communities where we work and live.
Specifically, Waters focuses on supporting organizations dedicated to education and healthcare, in addition to actively supporting local organizations dedicated to the arts, health and human services, recreation, education, and the environment.
Over the past years, Waters educational support has ranged from supporting science and healthcare career development to supporting community education through science museums and local school systems.
Waters has provided educational grants for advanced degrees and participated in recognition programs that foster scientific advancement.
Waters continues to actively seek fundraising opportunities to support some of the finest healthcare institutions in the world.
In addition to supporting educational programs in our community, Waters created the Waters Scholarship Program for children of its employees worldwide.
This program recognizes outstanding academic ability and potential by providing scholarships for undergraduate study.
The selection of the recipients is based on academic merit.
Supporting the development and understanding of science and improving the quality of healthcare are core values of Waters and drivers for our community support efforts.
One of the charitable partnerships Waters is most proud of is with the American Red Cross.
There are no shortages of natural disasters around the world and the victims of these events are often in immediate need of support.
This was the case following the 2004 tsunami that hit Southeast Asia, and the 2005 hurricane that ravaged the Gulf Coast region of the United States.
the Community Supporting the development and understanding of science and improving the quality of healthcare are core values of Waters, and drivers for our community support efforts.
they had the resources needed to provide relief efforts.
contribution and employee engagement efforts in their support.
Waters views our partnership with the American Red Cross as a long-term commitment to do our part no matter where in the world crisis occurs.
Not only is Waters proud of its own charitable giving, we are especially proud of our employees who consistently contribute to charitable organizations of their choice.
Waters is committed to providing our employees with programs and resources that encourage and recognize employee innovation, collaboration, accountability, and results.
Waters has approximately length of service of nine years.
We are proud of the long service of our employees and their dedication to Waters, our customers, and our shareholders.
taking into account all aspects of what an individual contributes and receives as a Waters employee.
a rewarding career, and a culture of support.
The more effective Waters is at fulfilling our commitment to employees, the more successful and valuable employees become.
variety of regional programs and services, such as medical coverage.
Waters efforts to assist employees in producing a secure future are highlighted by a global compensation philosophy of pay for performance and a variety of compensation programs that reward employees for their contributions to Waters success.
Our compensation programs are designed to establish competitive compensation levels within relevant markets and affordable resources.
In addition, Waters partners with employees in preparing for retirement through company sponsored retirement plans where appropriate.
Helping an employee develop a rewarding career is a win-win proposition.
Waters accomplishes this through our performance management programs and by supporting an employee’s personal development.
Waters provides employees with development opportunities, comprehensive learning and educational assistance program, as well as valued service and recognition awards.
Lastly are Waters efforts to create a culture of support.
From personal accountability training to quality of work life, Waters looks to each employee to be responsible for maximizing their opportunities and improving the company as whole.
is providing a work environment that is consistent with our Code of Business Conduct and Ethics and includes a workplace free of discrimination and sexual harassment.
At the core of our sustainability practices is a commitment to our employees.
Our ability to succeed as a company dramatically grows with our ability to succeed as an employer.
to Work honor recognizes the most progressive companies in the state based on employee opinions about company leadership, compensation and training, diversity/inclusion, career development, familyfriendly flexibility, and values and ethics.
Waters corporation 34 Maple Street Milford, MA 01757 U.S.A. T: 508 478 2000 F: 508 872 1990 www.waters.com Waters, UltraPerformance Liquid Chromatography, and ACQUITY UPLC are registered trademarks of Waters Corporation.
HDMS, High Definition Mass Spectrometry, SYNAPT, and The Science of What’s Possible are trademarks of Waters Corporation.
a new company that will be stronger and more relevant than ever before.
Over our long history, BD has always been guided by our purpose and values, which are deeply rooted in improving healthcare.
in our values and cultural priorities; these priorities also highlight areas of capability enhancement, in line with BD’s new strategy.
We respect, collaborate, challenge and care about each other This report presents our performance after our first year working towards our 2020 Goals.
These goals have broadened the lens through which we view sustainability across four key areas— innovation, access, efficiency and empowerment.
Innovation: We repositioned BD as a global leader in medication management and healthcare safety solutions in entered the genomics space with the acquisitions of GenCell Biosystems and Cellular Research.
We also increased our investment in R&D and have more new products in our pipeline than ever before.
• Access: The BD-PEPFAR public-private partnership continues to enable improvements to the quality of diagnostics across six countries.
We have deployed more than serve as part of this program, the results of which were recently published in the Journal of Infectious Diseases.
In addition to progress against each of our energy, water and waste goals, our focus on reducing the environmental impact of our operations led to a decrease in greenhouse gas emissions, We also continue to introduce products that eliminate the use of chemicals we have targeted to reduce in our portfolio.
Empowerment: Our Volunteer Service Trip program celebrated its tenth year in with a unique opportunity to live our purpose while serving communities in need.
More than sites have participated in 16 volunteer trips since the program’s inception.
Our work in sustainability is centered upon addressing the global needs that are most relevant to our business.
As we move forward, we recognize the UN Sustainable Development Goals, ratified in our efforts.
Finally, I’m pleased to share that BD was listed on FORTUNE magazine’s first-ever “Change the World” list in acknowledges companies that make a sizable impact on major social or environmental problems as part of their competitive strategy.
We move forward with a firm ambition: to focus our work on creating a new and better healthcare company and—in so doing—to achieve our purpose of advancing the world of health.
At BD, we have the unique opportunity to fulfill our life’s work through our work life, and we take seriously our ability to serve unmet societal needs through business models and initiatives that also contribute to our commercial success.
I look forward to sharing our journey with you now and in future reports.
This report provides an update of our global environmental, social and governance (ESG) performance against BD’s goals, during our fiscal year 2015 (October 1, 2014, to September 30, 2015) for BD and our subsidiaries, unless otherwise stated.
In order to better align with BD’s financial year, a full 2016 sustainability report using version 4.0 of the Global Reporting Initiative (GRI) guidelines will be issued early calendar year 2017.
While this report is not intended to meet the requirements of version Standard Disclosures have been included where full or partial information has been provided.
Reporting and performance data includes information on BD’s owned and operated facilities; this includes BD’s acquisition of CareFusion Corporation, which was completed in 2015.
The report content is limited to BD's performance against our material ESG issues for the Company.
$ $1.2 Other2 $2.4 Europe 1 Values in this exhibit reflect rounded numbers.
Structured to serve customers with unique solutions 2020 sustainability goals In July 2015, BD launched new sustainability goals for 2020.
our industry while helping to make a difference on relevant issues that affect society and the planet.
In addition to an ongoing focus on improving environmental performance, our sustainability strategy now takes a broader view of BD’s role in addressing global societal issues.
The following report provides a brief overview of our performance against each of these goals over the past year.
With recent acquisitions, particularly that of CareFusion, BD is evolving.
In recognition of our sustained efforts to create a culture of innovation, BD was honored by the Product Development and Management Association (PDMA) with the Corporate Innovator (OCI) Award.
of its kind, the OCI Award honors organizations that have demonstrated five or more years of sustained and quantifiable innovation success.
BD was recognized for our vast, innovative contributions to the healthcare industry as a leading medical technology company.
Awards: BD received prestigious awards from Frost & Sullivan.
In medication management industry with the acquisition of CareFusion.
The new extended portfolio of products provides a complete end-to-end solution from pharmacies to patients.
The CareFusion SmartWorks platform serves as the communication backbone between our solutions and health IT systems, allowing BD to offer a safer and more efficient way to procure, store, prep, track, dispense, administer and analyze medications across a health system and the entire continuum of care.
In management system, the first-of-its-kind medication management solution for manual IV bolus injections.
It is the first and only solution to provide real-time drug identification, dose measurement and allergy detection at the point of injection, while wirelessly sending captured information directly to the patient’s electronic medical record (EMR) following medication administrations.
BD Intelliport also received the prestigious Sullivan Award for New Product Innovation.
Also in acquired CRISI Medical Systems, a medical technology company dedicated to improving the safety and delivery of IV injectable medications.
BD and CRISI jointly developed the BD Intelliport medication management system.
In introduce a new insulin pump infusion set with BD FlowSmart technology.
This agreement represents an important collaboration between two leading diabetes device companies uniting to address unmet needs and improve infusion set options for people with diabetes using insulin pumps.
BD entered the genomics space with the acquisitions of GenCell Biosystems and Cellular Research in 2015.
Combined with our more than technologies, we’re seeking to improve the sample management process in the fast-growing area of nextgeneration sequencing (NGS) by helping customers increase workflow efficiency, improve outcomes and reduce costs.
In which is optimized for use with the BD Horizon Brilliant™ reagent portfolio and offers simultaneous measurement of up to 14 different single-cell characteristics, opening up new avenues of investigation and a deeper level of biological study.
In made available with optional camera-based, visual documentation hardware.
This hardware solution includes an embedded barcode scanner and camera that provide visual documentation and barcode confirmation of vial, syringe and IV containers during each preparation step.
The solution enables remote verification of IV admixtures as well as a visual record of each step, further enhancing the safety and efficiency afforded by the BD Cato offering.
into a Corporate Partners Sponsorship Agreement for the university’s business accelerator program, FastForward.
and commercialization of an array of innovations derived both at the university and elsewhere in Baltimore.
on topics likely to be of interest to the startups.
BD partners with Microsoft to build cloud services in Azure to enable Health IT solutions that increase patient safety, improve medication management and enhance healthcare delivery efficiency.
These solutions not only solve present needs, but will enable healthcare systems to move closer to population health management.
test results from the BD Veritor platform to the BD cloud.
The BD cloud then transmits the data in a highly secure manner to a laboratory information system or electronic health records system.
across the public, private and nonprofit sectors to catalyze new technologies and solutions.
BD FACSPresto™ system The BD FACSPresto system, launched in infrastructure across Africa, Asia and Latin America.
The BD FACSPresto system provides information on absolute CDcount, CD4 percentage and hemoglobin levels in a patient.
The World Health Organization (WHO) recommends that all people with HIV who are starting ARV treatment have a baseline CD4 assessment done.
They also recommend the use of CDco-infected with TB or other infections.
The BD FACSPresto system can be placed in district hospitals and health centers, thus expanding access to enable people with HIV / AIDS to get onto a treatment pathway, reducing the probability of transmitting the infection to others and providing a plan for improved long-term care.